Literature DB >> 28951184

Schwannomas of the Frontal Sinus: Cases and Review of the Literature.

Asha Iyer1, Annika Meyer2, Alfred Marc Iloreta3, Satish Govindaraj4, Brett Miles4, Raj Shrivastava1.   

Abstract

BACKGROUND: Although schwannomas are commonly found in the head and neck region, sinonasal tract involvement is extremely rare, estimated as <4%. The presence of these lesions in the frontal sinus is even less common. CASE DESCRIPTION: Two patients presented with schwannomas originating in the frontal sinus with variable degrees of extension. These patients underwent resection of the tumors via an endoscopic or combined approach. The histologic diagnosis confirmed schwannoma in both cases.
CONCLUSIONS: Although these lesions have traditionally been approached through larger craniotomies and open procedures, we describe less invasive approaches for these rare frontal sinus schwannomas and demonstrate them as a valid alternative with minimal morbidity for patients.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Endoscopic; Frontal sinus; Schwannoma; Sinonasal

Mesh:

Year:  2017        PMID: 28951184     DOI: 10.1016/j.wneu.2017.09.046

Source DB:  PubMed          Journal:  World Neurosurg        ISSN: 1878-8750            Impact factor:   2.104


  2 in total

1.  Surgical and histological evidence of case reports showing Schwannomas in the nasal area.

Authors:  Pier Francesco Galzignato; Salvatore Chirumbolo; Walter Cestaro; Antonio Scapinello; Dario Bertossi; Riccardo Nocini
Journal:  Int J Surg Case Rep       Date:  2022-05-04

2.  Defining the limits and indications of the Draf III endoscopic approach to the lateral frontal sinus and maximizing visualization and maneuverability: a cadaveric and radiological study.

Authors:  Efstathios Papatsoutsos; Aristotelis Kalyvas; Evangelos Drosos; Eleftherios Neromyliotis; Christos Koutsarnakis; Spyridon Komaitis; Vasileios Chatzinakis; George Stranjalis; Christos Georgalas
Journal:  Eur Arch Otorhinolaryngol       Date:  2022-03-09       Impact factor: 3.236

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.